WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
August Renshaw
Associate
Patents and Innovations
San Diego
arenshaw@wsgr.com

D858-350-2349

Download vCard
Open PDF

August Renshaw is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on intellectual property matters related to chemistry, biochemistry, and pharmaceuticals as part of the patents and innovations group. August has represented clients of different sizes, ranging from small, early stage start-ups to large, well-established pharmaceutical companies.

Prior to attending law school, August worked as a research scientist at Pfizer La Jolla, working on bioprocess development as part of the vaccines research group. During this time, he worked on a wide range of technologies, ranging from conjugation platforms to production of therapeutic viruses and viral particles. In graduate school, August worked in a marine natural products laboratory focused on the elucidation of the structures of new natural products and the development of analytical methods.

Experience

August Renshaw is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on intellectual property matters related to chemistry, biochemistry, and pharmaceuticals as part of the patents and innovations group. August has represented clients of different sizes, ranging from small, early stage start-ups to large, well-established pharmaceutical companies.

Prior to attending law school, August worked as a research scientist at Pfizer La Jolla, working on bioprocess development as part of the vaccines research group. During this time, he worked on a wide range of technologies, ranging from conjugation platforms to production of therapeutic viruses and viral particles. In graduate school, August worked in a marine natural products laboratory focused on the elucidation of the structures of new natural products and the development of analytical methods.

Education
  • J.D., University of San Diego School of Law, 2020
  • M.S., Chemistry, University of California, San Diego, 2013
  • B.S., Chemistry/Biochemistry, University of California, San Diego, 2012
Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., University of San Diego School of Law, 2020
  • M.S., Chemistry, University of California, San Diego, 2013
  • B.S., Chemistry/Biochemistry, University of California, San Diego, 2012
Admissions
  • State Bar of California
  • U.S. Patent and Trademark Office

Biological Sciences and Biotechnology

  • Antibody
  • Biochemistry
  • Bioconjugation
  • Biologics
  • Cancer therapeutics
  • Immuno-oncology

Therapeutics and Drug Discovery

  • Drug conjugates
  • Peptide therapeutics
  • Small molecule synthesis
  • Small molecules
  • Vaccines

Chemistry and Material Science

  • Chemical synthesis
  • Chemistry
  • Organic chemistry
  • Protein engineering
Technical Fluency

Biological Sciences and Biotechnology

  • Antibody
  • Biochemistry
  • Bioconjugation
  • Biologics
  • Cancer therapeutics
  • Immuno-oncology

Therapeutics and Drug Discovery

  • Drug conjugates
  • Peptide therapeutics
  • Small molecule synthesis
  • Small molecules
  • Vaccines

Chemistry and Material Science

  • Chemical synthesis
  • Chemistry
  • Organic chemistry
  • Protein engineering
Focus Areas
  • Biotech
  • Intellectual Property
  • Life Sciences
  • Patents and Innovations
Recent Insights
Client Highlights
Wilson Sonsini Advises Belite Bio on Patent Matters Related to $350 Million Public Offering of American Depositary Shares
On December 1, 2025, Belite Bio, a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, announced the pricing of an underwritten public offering at approximately $350 million. Wilson Sonsini Goodrich & Rosati has advised Belite Bio on patent matters since the company's inception, in addition to FDA regulatory, licensing, and litigation matters, and counseled Belite on patent matters related to this latest offering.
Learn More
Client Highlights
Wilson Sonsini Advises LuxWall on Patent Matters Related to Partnership with Saint-Gobain Glass
On September 22, 2025, Saint-Gobain Glass, a leader in flat glass for building applications, and LuxWall, the pioneer in transparent insulation technology, announced a strategic partnership to bring INSIOTMnext-generation vacuum glazing to the European market. Wilson Sonsini Goodrich & Rosati created LuxWall’s patent strategy and advised the company on patent matters related to the transaction.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.